MSD’s Keytruda wins bladder cancer indication in Japan
Related Biotechnology, Pharmaceutical and Healthcare News
Becomes first anti-PD1 approved in the country for previously treated UC
Original Article: MSD’s Keytruda wins bladder cancer indication in Japan
NEXT ARTICLE
More From BioPortfolio on "MSD’s Keytruda wins bladder cancer indication in Japan"